Radiomic Analysis for Predicting Treatment Response and Clinical Outcomes in Malignancies
NCT ID: NCT05170087
Last Updated: 2023-04-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1200 participants
OBSERVATIONAL
2020-03-02
2025-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Radiomic Markers for Breast Cancer Metastasis and Treatment Response Using MRI
NCT03709186
MR Characterisation/Localisation of Breast Cancer
NCT01567137
Dynamic Breast MRI in Assessing Locally Advanced Breast Cancer
NCT00455273
Visualization Tool for Investigation of Breast Lesions
NCT00934297
Radiomics of Mp-MRI Assessing NAC Outcome in Breast Cancer
NCT03592004
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breast malignancies
Those diagnosed with breast malignancies
No interventions assigned to this group
Head and Neck malignancies
Those diagnosed with head and neck malignancies
No interventions assigned to this group
Brain malignancies
Those diagnosed with brain malignancies
No interventions assigned to this group
Gynecological malignancies
Those diagnosed with gynecological malignancies
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Treated with radiation at Odette Cancer Centre between 2010 and 2019
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sunnybrook Health Sciences Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Gregory Czarnota
Radiation Oncologist and Clinical Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gregory Czarnota, Ph.D. M.D.
Role: PRINCIPAL_INVESTIGATOR
Sunnybrook Health Sciences Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
034-2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.